Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATOVAQUONE for Antiviral prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 62 adverse event reports in the FDA FAERS database where ATOVAQUONE was used for Antiviral prophylaxis.

Most Reported Side Effects for ATOVAQUONE

Side Effect Reports % Deaths Hosp.
Off label use 176 7.7% 62 93
Drug ineffective 164 7.2% 77 84
Condition aggravated 145 6.4% 36 68
Thrombocytopenia 127 5.6% 55 86
Pyrexia 117 5.2% 13 76
Rash 108 4.8% 8 59
Neutropenia 89 3.9% 6 47
Diarrhoea 86 3.8% 12 43
Pneumocystis jirovecii pneumonia 83 3.7% 13 47
Product use in unapproved indication 83 3.7% 18 38
Pancytopenia 76 3.3% 9 34
Agranulocytosis 69 3.0% 3 45
Thrombotic microangiopathy 67 3.0% 51 53
Febrile neutropenia 64 2.8% 9 22
Nausea 64 2.8% 3 31

Other Indications for ATOVAQUONE

Product used for unknown indication (515) Antifungal prophylaxis (319) Prophylaxis (314) Pneumocystis jirovecii pneumonia (258) Babesiosis (173) Infection prophylaxis (142) Opportunistic infection prophylaxis (40) Pneumonia (35) Malaria prophylaxis (31) Lyme disease (28)

Other Drugs Used for Antiviral prophylaxis

PALIVIZUMAB (3,080) VALGANCICLOVIR (1,515) VALACYCLOVIR (1,050) ACYCLOVIR (749) LETERMOVIR (574) GANCICLOVIR (463) OSELTAMIVIR (444) LAMIVUDINE (299) NIRSEVIMAB-ALIP (137) SULFAMETHOXAZOLE\TRIMETHOPRIM (123)

Related Pages

ATOVAQUONE Full Profile All Antiviral prophylaxis Drugs ATOVAQUONE Demographics ATOVAQUONE Timeline